asp-1929
Small moleculeexperimental
Clinical trial activity
5 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
5
Phase 3
2
Phase 4
0
Earliest trial started May 9, 2019 (NCT03769506)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06699212 | Phase 3 | Nov 30, 2024 | Rakuten |
| NCT05265013 | Phase 2 | Apr 19, 2022 | Rakuten |
| NCT05182866 | Phase 2 | Jan 21, 2022 | National Cancer Institute (NCI), Rakuten |
| NCT04305795 | Phase 1/Phase 2 (Phase 2) | Sep 30, 2020 | Rakuten |
| NCT03769506 | Phase 3 | May 9, 2019 | Rakuten |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Rakuten | For profit | 5 | 5 | 2 | 2019 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2022 |
2 organizations
Page 1 / 1